La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
ICU Medical Gestion
Gestion contrôle des critères 3/4
Le PDG ICU Medical's est Vivek Jain, nommé en Feb2014, a un mandat de 10.5 ans. La rémunération annuelle totale est $ 6.81M, composée du salaire de 11.4% et des bonus 88.6%, y compris les actions et options de la société. détient directement 0.79% des actions de la société, d'une valeur de $ 30.13M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 6.6 ans et 6.6 ans.
Informations clés
Vivek Jain
Directeur général
US$6.8m
Rémunération totale
| Pourcentage du salaire du PDG | 11.4% |
| Durée du mandat du directeur général | 10.6yrs |
| Propriété du PDG | 0.8% |
| Durée moyenne d'occupation des postes de direction | 6.7yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 6.7yrs |
Mises à jour récentes de la gestion
Recent updates
ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Bounce 30% But Its Business Still Trails The Industry
Aug 18
ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly
Aug 07ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult
Jun 27ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price
Jun 23Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package
May 09Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S
Apr 26ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Mar 31Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?
Jan 31ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business
Jan 04These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively
Oct 28Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?
Oct 07ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Jul 19Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Jun 22Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt
Apr 03Estimating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Feb 27ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Dec 07ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Sep 07ICU Medical Hit Hard As Smiths Medical Needs Significant TLC
Aug 20ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M
Aug 08FDA labels ICU Medical unit's April recall of syringe infusion pumps as most serious
Jul 20ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Jun 08ICU Medical: There Is Still Upside Here As Management Goes Big To Drive Value
Mar 25A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Feb 23Analysts Just Made A Significant Upgrade To Their ICU Medical, Inc. (NASDAQ:ICUI) Forecasts
Jan 28Is Now The Time To Put ICU Medical (NASDAQ:ICUI) On Your Watchlist?
Dec 05Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$71m |
| Mar 31 2024 | n/a | n/a | -US$59m |
| Dec 31 2023 | US$7m | US$775k | -US$30m |
| Sep 30 2023 | n/a | n/a | -US$28m |
| Jun 30 2023 | n/a | n/a | -US$48m |
| Mar 31 2023 | n/a | n/a | -US$46m |
| Dec 31 2022 | US$6m | US$756k | -US$74m |
| Sep 30 2022 | n/a | n/a | -US$39m |
| Jun 30 2022 | n/a | n/a | US$5m |
| Mar 31 2022 | n/a | n/a | US$41m |
| Dec 31 2021 | US$5m | US$650k | US$103m |
| Sep 30 2021 | n/a | n/a | US$109m |
| Jun 30 2021 | n/a | n/a | US$103m |
| Mar 31 2021 | n/a | n/a | US$94m |
| Dec 31 2020 | US$3m | US$650k | US$87m |
| Sep 30 2020 | n/a | n/a | US$81m |
| Jun 30 2020 | n/a | n/a | US$83m |
| Mar 31 2020 | n/a | n/a | US$87m |
| Dec 31 2019 | US$3m | US$650k | US$101m |
| Sep 30 2019 | n/a | n/a | US$73m |
| Jun 30 2019 | n/a | n/a | US$47m |
| Mar 31 2019 | n/a | n/a | US$55m |
| Dec 31 2018 | US$6m | US$650k | US$29m |
| Sep 30 2018 | n/a | n/a | US$86m |
| Jun 30 2018 | n/a | n/a | US$86m |
| Mar 31 2018 | n/a | n/a | US$18m |
| Dec 31 2017 | US$4m | US$650k | US$69m |
Rémunération vs marché: La rémunération totale de Vivek ($USD 6.81M ) est dans la moyenne des entreprises de taille similaire sur le marché US ($USD 6.76M ).
Rémunération et revenus: La rémunération de Vivek a augmenté alors que l'entreprise n'est pas rentable.
PDG
Vivek Jain (52 yo)
10.6yrs
Titularisation
US$6,810,975
Compensation
Mr. Vivek Jain has been an Independent Director of Envista Holdings Corporation since April 07, 2020. Mr. Jain has been Chairman and Chief Executive Officer of ICU Medical, Inc. since February 13, 2014. Mr...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Chairman of the Board | 10.6yrs | US$6.81m | 0.79% $ 32.0m | |
| CFO & Treasurer | 4.5yrs | US$4.39m | 0.10% $ 4.1m | |
| Chief Operating Officer | 6.7yrs | US$4.40m | 0% $ 0 | |
| Corporate VP | 6.7yrs | US$2.47m | 0.018% $ 741.0k |
6.7yrs
Durée moyenne de l'emploi
51yo
Âge moyen
Gestion expérimentée: L'équipe de direction de ICUI est chevronnée et expérimentée (ancienneté moyenne 6.6 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Chairman of the Board | 10.6yrs | US$6.81m | 0.79% $ 32.0m | |
| Independent Director | 8.7yrs | US$265.14k | 0.0087% $ 352.1k | |
| Independent Director | 2.8yrs | US$255.14k | 0.0064% $ 258.4k | |
| Independent Director | 6.7yrs | US$282.14k | 0.012% $ 500.3k | |
| Independent Director | 3.2yrs | US$255.14k | 0.0077% $ 311.8k | |
| Lead Independent Director | 9.2yrs | US$296.14k | 0.023% $ 915.5k | |
| Independent Director | 6.7yrs | US$255.14k | 0.012% $ 500.3k |
6.7yrs
Durée moyenne de l'emploi
63yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de ICUI sont considérés comme expérimentés (ancienneté moyenne 6.6 ans).